EligibleTrials

Clinical trials recruiting for Chronic pain

58
Recruiting trials
28
US states with sites
19
Countries
24%
Accept healthy volunteers

Phase breakdown

Phase 2 4Phase 4 1Not applicable 53

Drugs and treatments being studied

InterventionTrials
Ketamine2
Dextrose 5% and Lidocaine1
Herbal medicine1
IV Vitamin Infused Therapy Treatment1
LY40659671
Lidocaine1
Oxytocin1
Psilocybin 25 mg1
therapeutic program including intermittent drug intake and multimodal rehabilitation program1

Where trials are recruiting (top US states)

StateRecruiting trials
North Carolina5
Florida3
Illinois3
Massachusetts3
Missouri3
Ohio3
Arizona2
California2
Connecticut2
Montana2
Pennsylvania2
Alabama1

Top cities

Chicago, Illinois 3Boston, Massachusetts 2Cincinnati, Ohio 2Durham, North Carolina 2Gainesville, Florida 2Helena, Montana 2St Louis, Missouri 2Winston-Salem, North Carolina 2Austin, Texas 1Baltimore, Maryland 1

Self-screener

Recruiting trials

Related conditions

Trials recruiting for Chronic pain often also study these conditions. Each links to its own recruiting-trial list.

Depression 1463Anxiety 1237Osteoarthritis 611Fibromyalgia 142Musculoskeletal Pain 12Knee osteoarthritis 167Chronic Pain Syndrome 5Migraine 184Endometriosis 166Alzheimer's disease 617

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Chronic pain trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.

Get notified when new trials open

One email when new recruiting trials are added. Unsubscribe anytime.